diabetes

Zafgen has something to cheer as diabetes drug makes the cut in PhII study, quelling cardio safety fears
Zafgen has something to cheer as diabetes drug makes the cut in PhII study, quelling cardio safety fears
Endpoints
Zafgen
diabetes
clinical trials
ZGN-1061
Flag link:
How a 'regulatory dead zone' may be holding up copycat insulin
How a 'regulatory dead zone' may be holding up copycat insulin
Biopharma Dive
diabetes
insulin
generics
FDA
Flag link:
Novo Nordisk’s first diabetes innovation challenge winners head to the lab
Novo Nordisk’s first diabetes innovation challenge winners head to the lab
Fierce Pharma
Novo Nordisk
diabetes
innovation
Flag link:
Diabetes tech execs talk patient-centric design, device development & trust
Diabetes tech execs talk patient-centric design, device development & trust
Mass Device
diabetes
patients
devices
clinical trials
Flag link:
Mylan, Biocon copy inches closer to challenging Sanofi's long-suffering Lantus
Mylan, Biocon copy inches closer to challenging Sanofi's long-suffering Lantus
Fierce Pharma
Sanofi
Lantus
Eli Lilly
Boehringer Ingelheim
Mylan Labs
generics
diabetes
insulin
basal insulin
Flag link:
Gottlieb blasts high insulin prices, touts far-off new rules he says will spur competition in that market
Gottlieb blasts high insulin prices, touts far-off new rules he says will spur competition in that market
Stat
FDA
Scott Gottlieb
insulin
diabetes
drug pricing
Flag link:
Novo keeps adding capacity, and jobs, to its North Carolina drug plant
Novo keeps adding capacity, and jobs, to its North Carolina drug plant
Fierce Pharma
Novo Nordisk
drug manufacturing
diabetes
North Carolina
Flag link:
Want to Sell Your Diabetes Drug? Put Real Patients in Ads
Want to Sell Your Diabetes Drug? Put Real Patients in Ads
Xtalks
patients
diabetes
DTC advertising
Flag link:
ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later
ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later
Xconomy
ViaCyte
stem cells
diabetes
IPOs
clinical trials
Flag link:
FDA Slaps Clinical Hold on Zafgen’s Lead Product Over Safety Concerns
FDA Slaps Clinical Hold on Zafgen’s Lead Product Over Safety Concerns
BioSpace
Zafgen
clinical trials
FDA
diabetes
ZGN-1061
type 2 diabetes
Flag link:
Millions left behind as diabetes drives surge in insulin demand
Millions left behind as diabetes drives surge in insulin demand
Reuters
diabetes
type 2 diabetes
insulin
Flag link:
It's Lights Out For Novartis And Verily's Glucose Monitoring 'Smart Lens' Project
It's Lights Out For Novartis And Verily's Glucose Monitoring 'Smart Lens' Project
Forbes
Novartis
Alcon
Verily
Alphabet
blood glucose monitoring
devices
diabetes
Flag link:
AstraZeneca's diabetes drug curbs heart failure, kidney risks
AstraZeneca's diabetes drug curbs heart failure, kidney risks
Yahoo/Reuters
AstraZeneca
Farxiga
diabetes
heart failure
Flag link:
Despite Trulicity success, Lilly can't escape diabetes concerns
Despite Trulicity success, Lilly can't escape diabetes concerns
Biopharma Dive
Eli Lilly
diabetes
earnings
Trulicity
Flag link:
No Matter What The FDA Decides, New Diabetes Drugs Will Still Require CV Outcomes Trials
No Matter What The FDA Decides, New Diabetes Drugs Will Still Require CV Outcomes Trials
Forbes
FDA
diabetes
cardiovascular outcomes
Flag link:
Eli Lilly touts MACE win for diabetes blockbuster Trulicity — a 'nice positive'
Eli Lilly touts MACE win for diabetes blockbuster Trulicity — a 'nice positive'
Endpoints
Eli Lilly
Trulicity
diabetes
Flag link:
Amazon eyes chronic health market with Arcadia Group’s Choice health brand launch
Amazon eyes chronic health market with Arcadia Group’s Choice health brand launch
Mass Device
Amazon
Arcadia
diabetes
hypertension
devices
Flag link:
FDA Accepts Xeris' Glucagon Rescue Pen NDA for Review
FDA Accepts Xeris' Glucagon Rescue Pen NDA for Review
CP Wire
Xeris Pharmaceuticals
diabetes
FDA
glucagon
Flag link:
FDA Accepts Xeris' Glucagon Rescue Pen NDA for Review
Xeris Pharmaceuticals
diabetes
Flag link:
Abbott CEO on Libre: ‘We’re just getting started’
Abbott CEO on Libre: ‘We’re just getting started’
Drug Delivery Business News
Abbott Labs
FreeStyle Libre
diabetes
devices
blood glucose monitoring
Flag link:

Pages